Global Biomarkers Market Overview And Statistics For 2024-2033

October 21, 2024 10:46 AM AEDT | By EIN Presswire
 Global Biomarkers Market Overview And Statistics For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, October 21, 2024 /EINPresswire.com/ -- The biomarkers market is projected to grow from $61.31 billion in 2023 to $69.54 billion in 2024, with a compound annual growth rate (CAGR) of 13.4%. This growth during the historical period can be attributed to advancements in genomics and proteomics technologies, the increasing prevalence of chronic diseases, a growing emphasis on personalized medicine, rising demand for companion diagnostics, and the expansion of applications in drug development.

What Is The Estimated Market Size Of The Global Biomarkers Market And Its Annual Growth Rate?
The biomarkers market is expected to reach $117.82 billion by 2028, with a compound annual growth rate (CAGR) of 14.1%. The growth during the forecast period can be attributed to an increasing focus on early disease detection and prevention, the expansion of biomarkers in oncology and immunotherapy, rising investments in precision medicine initiatives, the emergence of liquid biopsy as a non-invasive biomarker detection method, and a growing preference for biomarkers in drug discovery and development.

Explore Comprehensive Insights Into The Global Biomarkers Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=6485&type=smp

Growth Driver of The Biomarkers Market
The rising incidence of heart diseases is expected to drive the growth of the biomarkers market in the forecast period. The utilization of biomarkers for heart disease patients has significantly increased in recent years. Currently, natriuretic peptides are the most commonly used biomarkers, aiding in the diagnosis of heart failure. Additionally, circulating biomarkers like high-sensitivity C-reactive protein are employed for diagnosing heart failure. Heart disease remains one of the leading causes of death among various racial and ethnic groups in the United States. As heart diseases become more prevalent, the demand for biomarkers is likely to rise.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Which Market Players Are Driving The Biomarkers Market Growth?
Key players in the market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

What Are The Key Trends That Influence Biomarkers Market Share Analysis?
Leading companies in the biomarker market are embracing a strategic partnership approach to offer expanded decentralized clinical trials to individuals, businesses, and governments. These partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and enhance overall success.

How Is The Global Biomarkers Market Segmented?
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
5) By Application: Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others )

Geographical Insights: North America Leading The Biomarkers Market
North America was the largest region in the market in 2023. Asia-Pacific is expected to be the fastest-growing region in the report during the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Biomarkers Market Definition
Biomarkers are biological molecules that serve as indicators of a condition, disease, or abnormal process, and they can be found in tissues, body fluids, or blood. They are used to assess how effectively the body responds to treatment for a particular disease or condition. These biomarkers play a critical clinical role in refining or guiding treatment decisions.

Biomarkers Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

An overview of the global biomarkers market report covering trends, opportunities, strategies, and more
The Biomarkers Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on biomarkers market size, biomarkers market drivers and trends, biomarkers market major players and biomarkers market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Renal Biomarkers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Nuclear Imaging Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Scientific Research And Development Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

What Does the Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.